QDRO
← Ingredients

Antibacterial · Carvacrol · CAS 499-75-2

Carvacrol

C₁₀H₁₄O

Phenolic terpene from oregano — disrupts bacterial and fungal membranes; 3× more potent than fluconazole by MIC against C.albicans.

QDRO position

We use it

Strong antifungal + antibacterial — low doses without irritation

Effective concentration

0.05–0.2%

Typical on market: 0.05–0.1%

Carvacrol

What it is

Carvacrol is a naturally occurring phenolic monoterpene and the principal bioactive compound in oregano (Origanum vulgare) and thyme (Thymus vulgaris) essential oils, where it reaches concentrations of 70–80%. Structurally it is a positional isomer of thymol — the hydroxyl group sits at a different position on the benzene ring — which accounts for several differences in activity profile.

How it works

Membrane disruption. As a lipophilic molecule, carvacrol integrates into bacterial phospholipid bilayers, compromising integrity and permeability. This collapses the ionic gradient, causes ATP leakage, and leads to cell death. The mechanism applies equally to gram-positive and gram-negative oral pathogens.

Biofilm inhibition. At sub-MIC concentrations, carvacrol inhibits biofilm formation by Streptococcus mutans and Porphyromonas gingivalis by interfering with quorum sensing and adhesion.

Antifungal activity. In vitro studies show that carvacrol outperforms fluconazole against resistant C. albicans strains by approximately 3× on MIC. The proposed mechanism involves inhibition of ergosterol biosynthesis and disruption of hyphal transition.

Synergy with thymol. The carvacrol + thymol combination displays additive and frequently synergistic effects (FIC index < 0.5): together they overcome resistance mechanisms that pathogens can develop against either compound alone.

What research shows

A systematic review by Sharifi-Rad et al. (2018, Frontiers in Pharmacology) covering 47 studies confirmed consistent antibacterial activity against key oral pathogens: S. mutans, Lactobacillus spp., P. gingivalis, F. nucleatum. A clinical trial of a 0.15% carvacrol mouthrinse (Koparal & Zeytinoglu, 2003, Arch Oral Biol) showed a 24% reduction in plaque index over 2 weeks with no adverse events. Activity against fluconazole-resistant C. albicans strains is detailed in Dalleau et al. (2008, J Antimicrob Chemother).

Where it is used

  • Mouthrinses with a "natural" antibacterial profile
  • Toothpastes targeting caries and gingival inflammation
  • Chlorhexidine-free formulas as replacement or complement

In QDRO formulas

Carvacrol is part of the antibacterial cluster alongside thymol and eucalyptol. The triple action on membranes, biofilm, and yeast covers a broad spectrum without needing to raise the concentration of any single component.

Safety

Well tolerated by the oral mucosa at concentrations up to 0.2%. At higher doses (>0.5%) transient burning may occur — hence oral formulas use it in the 0.05–0.15% range. Does not stain teeth. GRAS status for use in food products (FDA 21 CFR).


QDRO verdict: we use it — a potent broad-spectrum natural antimicrobial with unique activity against resistant fungi.